Concord Biotech shares saw a significant jump on Wednesday. This surge followed the company’s announcement of receiving approval from the USFDA for its Mycophenolate Mofetil for Oral Suspension. This antimetabolite immunosuppressant is used in organ transplant patients.
Tata Consumer shares jump 3% after Q1 results. Here’s why Nomura, Motilal see strong upside potential
Tata Consumer Products shares rose 3% after the FMCG major reported a 27.8% YoY jump in Q1 FY27 net profit to Rs 427 crore, while